Cellecta, Inc.
Cellecta provides contract research services for the discovery and characterization of novel drug targets, and the development of novel therapeutics.
Cellecta’s genome-wide and targeted RNAi screening platform, which combines complex lentiviral shRNA expression libraries with HT sequencing, enables identification of genes regulating a variety of cellular responses and possible therapeutic targets and helps researchers identify new targets, prioritize known targets, characterize therapeutic mechanisms of action, and identify genes that induce an additive or synergistic response.
The approach is particularly useful in elucidating the mechanism of action for compounds and for investigators interested in identifying essential genes in cancer models.
Explore our products
Show all categoriesC
Top suppliers
United States Biological
230753 products
Carl Zeiss Microscopy
27 products
Eppendorf
1 products
Promega Corporation
11 products
Panasonic Healthcare Company
5 products
Life Technologies
1 products
Nikon Instruments Europe
11 products
Olympus Europa Holding GmbH
3 products
Leica Microsystems, Inc.
10 products
GE Healthcare Life Sciences
2 products
Tecan Trading AG
19 products
Beckman Coulter, Inc.
1 products
AB SCIEX
3 products
BD (Becton, Dickinson and Company)
1 products
RANDOX TOXICOLOGY
5 products
Randox Food Diagnostics
6 products